AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2023
Mar 15, 2023
34519_dirs_2023-03-15_689f460e-ce56-4357-a2a6-3f545e0ebe6e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2023-03-13
Reporting Person: Tomsche David Scott (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 400 | $5.20 | Acquired | 96826 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 300 | $5.24 | Acquired | 97126 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 200 | $5.25 | Acquired | 97326 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 900 | $5.37 | Acquired | 98226 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 80 | $5.34 | Acquired | 98306 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 3 | $5.24 | Acquired | 98309 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 7 | $5.24 | Acquired | 98316 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 10 | $5.23 | Acquired | 98326 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 100 | $5.24 | Acquired | 98426 | Direct |
| 2023-03-13 | Common Stock, $0.10 per value per share | D | 100 | $5.24 | Acquired | 98526 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 71 | $5.50 | Acquired | 98597 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 309 | $5.50 | Acquired | 98906 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 831 | $5.47 | Acquired | 99737 | Direct |
| 2023-03-14 | Common stock $0.10 per value per share | D | 100 | $5.53 | Acquired | 99837 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 69 | $5.53 | Acquired | 99906 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 31 | $5.53 | Acquired | 99937 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 69 | $5.53 | Acquired | 100006 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 31 | $5.53 | Acquired | 100037 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 69 | $5.53 | Acquired | 100106 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 31 | $5.53 | Acquired | 100137 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 31 | $5.53 | Acquired | 100168 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 69 | $5.53 | Acquired | 100237 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 100 | $5.53 | Acquired | 100337 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 69 | $5.53 | Acquired | 100406 | Direct |
| 2023-03-14 | Common Stock, $0.10 per value per share | D | 100 | $5.44 | Acquired | 100506 | Direct |
Footnotes
F1: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23